Appili Therapeutics
Canada-based anti-infective pharmaceutical development company. Learn more
Launch date
Employees
Market cap
AUD4.8m
Enterprise valuation
AUD16m (Public information from Sep 2024)
Share price
CAD0.03 APLI.TO
Halifax Nova Scotia (HQ)
Authorizing premium user...